Latest News Archive
Please select Category, Year, and then Month to display items
28 June 2022
|
Story Nonsindiso Qwabe
|
Photo ALBERT VAN BILJON
In conversation: Prof Petersen and Leanne Manas.
An outward-looking, globally competitive university that ranks among the top-tier universities in South Africa and on the continent, driven by a strong human-centred, diverse social-justice approach. This is at the heart of the vision
Prof Francis Petersen, Rector and Vice-Chancellor of the UFS, shared with multi-award-winning
news anchor
Leanne Manas during a sit-down conversation on Friday 22 July 2022.
Prof Petersen reflected on the great strides and difficulties faced during his first term, as well as navigating the UFS through the COVID-19 pandemic to position the institution in a strategic and focused manner as a university of choice on the continent
and in other parts of the globe.
Prof Prakash Naidoo, Vice-Rector: Operations, introduced Leanne Manas
Prof Francis Petersen
Leanne Manas and Prof Petersen In conversation
Leanne Manas
Leanne Manas meeting our staff members.
Leanne Manas meeting our staff members.
Leanne Manas meeting our staff members.
Prof Petersen with some of our staff members
From the left; Prof Prakash Naidoo, Leanne Manas, Prof Francis Petersen and Temba Hlasho, Executive Director: Student Affairs
Leanne Manas meeting our staff members.
From the left; Prof Prakash Naidoo, Prof Francis Petersen and Quinton Koetaan, Senior Director; HRA
Leanne Manas meeting our staff members.
New research informs improved treatment of brain inflammation
2017-10-13
Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish
Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology.
Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.
Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs.
Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology